No Data
No Data
Stocks that moved the previous day part 2: Ikuyo, Tasukawa Electricity, QPS Research Institute, etc.
Stock Name <Code> 26th closing price⇒Compared to the previous day, deere & co Life <3245> 860 -36 Due to the ex-dividend rights fall at the end of the month, Round One <4680> 1050 -33 The impact of the dividend and preferential rights fall is predominant. Petroleum Resource Development <1662> 1060 -30 Due to the decline in crude oil prices following the production increase report. JVC Kenwood <6632> 1358 -61 Also, profit-taking sales are gathering in a scenario in the high price range. ENEOS <5020> 787.6 -19.0 To offset the decline in crude oil prices.
Emerging markets stock digest: Bushiroad soars significantly, Rice Curry hits limit up.
<7803> Bushiroad 377 +24 significantly extended. It announced the implementation of a share buyback after the close of trading on the 26th, and the favorable buying inflow ensued. The upper limit of shares that can be acquired is 2.5 million shares (3.56% of the issued shares excluding treasury shares), or 1 billion yen. The period is from October 1, 2024 to February 28, 2025. Taking into account the stock price level, available funds, and business environment, the active repurchase of treasury shares contributes to enhancing shareholder value.
Hot stocks digest (morning): Mitsukiko, Higasi Elec, Rice Curry, etc.
Sanmoki Co., Ltd. <1961>: ¥2386 (+¥108) soared significantly. At Tokai Tokyo Securities, the investment judgment has been newly set to "outperform," with a target stock price of ¥3000. Strong demand for equipment installation such as semiconductors and rechargeable battery factories is expected to lead to increased profitability, indicating potential for stock price growth based on valuations like the P/E ratio. It is considered that a full-fledged phase of profit expansion will begin from the fiscal year ending March 2024, and the operating profit for the fiscal year ending March 2025 is projected to be ¥12.5 billion according to the company's plan.
Lear Pharmaceuticals---Continues to rise, gastric acid secretion inhibitor tegoprazan approved for sale in Malaysia.
Advancing. The announcement that the gastric acid secretion inhibitor tegoprazan has obtained sales approval in Malaysia, leading to buying activity. Tegoprazan is a new mechanism of action gastric acid secretion inhibitor known as a potassium ion competitive acid blocker created by the company. The company holds the right to receive a share of the revenue that HK Inoen, its derivative, receives from its partners based on the license agreement with HK Inoen. This time, the company will not receive any lump sum payment, but sales.
Supported by a firm US stock market, but there may be a heavy resistance to price increases.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to show a solid performance. In the U.S. stock market on the 26th, the Dow Jones Industrial Average rebounded, closing 260.36 points higher (+0.62%) at 42,175.11 points, exceeding expectations. The economic indicators outperformed expectations, and the Chinese government's policy to strengthen financial support to achieve growth targets improved economic outlook, supporting stock prices. The Nasdaq was boosted by the rise of Micron (MU) in the semiconductor sector. Today's emerging markets are expected to have a dominant buying trend.
Crowdworks, Lear Pharmaceuticals, and others.
<195A> Acquired the stocks of Matsumura Shoten, which handles original fashion accessories, planning, manufacturing, and sales such as wallets, pouches, and bags for kids and teens, and subsidiary <3646> Acquired all the shares of Otosei, which is engaged in the station search IT solutions business, and made it a wholly-owned subsidiary <3900> Selected as a lease stock for Cloud Works <4579> Obtained approval for the sale of the acid secretion inhibitor, Tegoprazan, a Rakuria drug, in Malaysia <4881> Fanpep 11th
No Data
No Data